Clinical trialNCT04338581CompletedPhase 2Interventional

Evaluation of AMG 714 for Vitiligo

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment60Vitiligo

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is designed to evaluate the efficacy of AMG 714 for the treatment of adult participants with vitiligo.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Brett A. King, MD, PhD
Yale University School of Medicine: Department of Dermatology
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California, Irvine: Department of Dermatology
Irvine, California, United States
University of California Davis Health System: Department of Dermatology
Sacramento, California, United States
Yale University School of Medicine: Department of Dermatology
New Haven, Connecticut, United States
Tufts Medical Center: Department of Dermatology
Boston, Massachusetts, United States
University of Massachusetts Medical School
Worcester, Massachusetts, United States
Henry Ford Health System
Detroit, Michigan, United States
Northwell Health
Lake Success, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AMG 714Placebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 11 Dec 2020
Primary completion: 16 Oct 2024
Completion: 2 Apr 2025
Last update posted: 21 Apr 2026
Registered enrollment: 60
Registry id: NCT04338581

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.